Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4

OBJECTIVE: While the anticipated rise of disease‐modifying therapies calls for reliable trial outcome parameters, fluid biomarkers are lacking in spastic paraplegia type 4 (SPG4), the most prevalent form of hereditary spastic paraplegia. We therefore investigated serum neurofilament light chain (sNf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, Christoph, Serna‐Higuita, Lina Maria, Wilke, Carlo, Rattay, Tim W., Hengel, Holger, Reichbauer, Jennifer, Stransky, Elke, Leyva‐Gutiérrez, Alejandra, Mengel, David, Synofzik, Matthis, Schöls, Ludger, Martus, Peter, Schüle, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935322/
https://www.ncbi.nlm.nih.gov/pubmed/35171517
http://dx.doi.org/10.1002/acn3.51518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935322/
https://www.ncbi.nlm.nih.gov/pubmed/35171517
http://dx.doi.org/10.1002/acn3.51518

Ejemplares similares